Unlisted Deals:
ador powertron 500.00 (4,900.00 %) amol minechem 601.00 (0.17 %) anglo french drugs 950.00 (2.15 %) anugraha valve 510.00 (0.99 %) apl metals 40.00 (-2.44 %) apollo fashion 92.00 (-4.17 %) arkfin investments 50.00 arohan 250.00 (-1.96 %) assam carbon 310.00 (-1.59 %) avalokiteshvar 242.00 (0.83 %) axles india 680.00 (0.74 %) balmer lawrie 200.00 (-0.99 %) bharat hotels 375.00 (-1.32 %) bima mandi 235.00 (-2.08 %) bira 545.00 (-0.91 %) blsx limited 35.00 (2.94 %) boat 1,550.00 (-1.90 %) c & s electric 1,070.00 (1.90 %) cable corporation 24.50 (2.08 %) capgemini 14,600.00 (-1.02 %) care health 185.00 (-1.60 %) carrier aircon 550.00 (0.92 %) cial 470.00 (-1.05 %) csk 198.00 (-0.50 %) dalmia refract 270.00 (-1.82 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 445.00 (1.14 %) electronica plastic 4,500.00 (2.27 %) elgi ultra 400.00 elofic industries 2,850.00 (1.79 %) esl steel 42.00 (-2.33 %) fincare business 87.00 (1.16 %) fincare sfbl 205.00 (1.49 %) finopaytech limited 149.00 (-0.67 %) flipkart india 231,001.00 (0.00 %) frick india 3,500.00 (-1.41 %) gkn driveline 1,750.00 (2.94 %) goodluck defence 296.00 (-1.00 %) group pharma 300.00 gynofem healthcare 59.00 (-1.67 %) hazira cargo terminals limited 205.00 (1.49 %) hdb financial 1,210.00 (-1.22 %) hdfc ergo 370.00 (1.70 %) hdfc securities 11,300.00 (-2.59 %) hella india 900.00 (-2.17 %) hero fincorp 1,980.00 (-0.50 %) hexaware 985.00 (-0.51 %) hicks 1,600.00 (1.59 %) hira ferro 200.00 (2.56 %) honeywell electrical 7,200.00 (1.41 %) ikf finance 320.00 (-3.03 %) incred financial 10.00 (1.01 %) incred holdings 156.00 (-1.27 %) india carbon 1,120.00 (-1.32 %) india exposition 121.00 (0.83 %) indian potash 3,100.00 (-1.59 %) indian seamless 195.00 (2.63 %) indo alusys 25.75 (-0.96 %) indofil 1,430.00 (-0.69 %) infinite computer 405.00 (1.25 %) inkel 22.50 (-2.17 %) jana small finance bank 75.00 kel 575.00 (0.88 %) kial 137.00 (-0.72 %) klm axiva 15.50 (3.33 %) kurlon limited 1,275.00 (1.59 %) lava 45.00 (-2.17 %) mahindra rural mrhfl 100.00 manipal housing 74.00 (2.07 %) manjushree technopack 875.00 (0.57 %) martin & harris 820.00 (-1.20 %) matrix gas 810.00 (-2.41 %) merino 3,250.00 (-1.52 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 435.00 (1.16 %) mobikwik 640.00 (-1.54 %) mohan meakin 2,400.00 (2.13 %) mohfl 13.25 (-1.85 %) msei 1.80 (-2.70 %) msil 34.00 (3.03 %) nayara energy 690.00 (1.47 %) nayara energy ncd 320.00 (1.59 %) ncdex 200.00 (-0.99 %) ncl buildtek 310.00 (-3.13 %) ncl holdings 106.00 (0.95 %) nsdl 850.00 (3.03 %) nse india 1,850.00 (-2.63 %) onix renewable 16,000.00 (6.67 %) orbis financial 400.00 (-1.23 %) oswal minerals 60.10 (-1.48 %) otis elevator 4,100.00 (2.50 %) oyo rooms 53.00 (-1.85 %) panasonic appliances 262.00 (0.77 %) paymate india 500.00 (-1.96 %) pharmeasy 8.50 (3.03 %) pharmed limited 620.00 (0.81 %) philips domestic 675.00 (-1.46 %) philips india 925.00 (-0.54 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 265.00 (1.92 %) rapido 16,650.00 (0.03 %) rasoi 82,000.00 (2.50 %) reliance gic 480.00 (-2.04 %) resins plastics 525.00 (-0.94 %) ring plus aqua 560.00 (1.82 %) rrp s4e innovation 300.00 (-3.23 %) sab miller 535.00 (0.94 %) sbi amc 2,650.00 (-1.12 %) sbi general insurance 621.00 (0.16 %) scottish assam 505.00 (1.00 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,325.00 (-1.85 %) smile microfinance 51.00 (-1.92 %) sterlite grid 5 275.00 (-3.51 %) sterlite power 590.00 (-1.67 %) studds 980.00 (3.16 %) svsml 315.00 (2.94 %) t stanes 800.00 (1.27 %) tata capital 900.00 (-1.10 %) trl krosaki 1,750.00 (-1.41 %) urban tots 64.00 (-1.54 %) utkarsh coreinvest 290.00 (-1.69 %) vikram solar 445.00 (-1.11 %) vivriti capital 1,040.00 (-0.95 %)
×

Martin And Harris Annual Reports, Balance Sheet and Financials

Martin And Harris Laboratories Limited (Martin & Harris) Return Comparision with Primex 40 Index

Periods 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years All Time
Primex-40
Martin And Harris Laboratories Limited

Martin and Harris Laboratories Limited Balance Sheet (Rs in Lakhs)

Particulars

31-03-2024

31-03-2023

Non-current Assets

 

 

Property, plant, and equipment

1,776.07

1,553.31

Capital work-in-progress

-

340.65

Investment property

3,540.38

3,755.64

Investments

3,416.83

2,462.52

Deferred tax assets (net)

-

1.09

Current Assets

 

 

Inventories

197.22

1,880.88

Trade receivables

3,045.99

136.91

Cash and cash equivalents

24.62

82.47

Bank balances other than

4,412.30

6.3

Loans

-

3,009.46

Other financial assets

47,847.22

47,031.60

Current tax assets (net)

96.08

124.83

Other current assets

1,839.81

1,080.56

TOTAL ASSETS

66,196.51

61,466.23

EQUITY AND LIABILITIES

 

 

Equity share capital

399.6

399.6

Other equity

62,807.34

58,929.10

Non-current liabilities

 

 

Other financial liabilities

24.00

24.00

Provisions

23.35

68.32

Other non-current liabilities

12.84

15.16

Deferred tax liabilities (Net)

12.68

-

Current liabilities

 

 

Borrowings

782.7

418.68

Total outstanding dues of creditor other than Micro enterprises and small enterprises

1,683.40

972.69

Other financial liabilities

280.91

430.77

Provisions

13.93

38.22

Other current liabilities

100.09

169.69

Income tax liabilities (net)

55.67

-

TOTAL EQUITY AND LIABILITIES

66,196.51

61,466.23

Martin and Harris Laboratories Limited Profit & Loss Statement (Rs in Lakhs)

Particulars

31-03-2024

31-03-2023

Income

 

 

Revenue from operations

14,614.70

20,516.48

Other income

3,429.00

2,408.43

Total Income

18,043.70

22,924.91

Expenses

 

 

Cost of material, operation, and incidental cost

4,123.61

4,713.88

Employee benefits expenses

2,386.57

2,474.97

Finance costs

58.11

21.6

Depreciation and amortisation expenses

463.14

392.85

Other expenses

5,490.02

6,112.94

Total expenses

12,521.46

13,716.22

Profit before tax

5,522.24

9,208.69

Tax expense

 

 

Current tax

1,482.36

2,414.51

Deferred tax

-8.15

-16.59

Tax in respect of earlier years

5.19

3.89

Profit for the year

4,042.84

6,806.88

Other comprehensive income/(loss) for the year

 

 

Items that will not be reclassified to profit or loss

 

 

Remeasurements of defined benefit liability / (asset)

67.15

3.27

Income tax on remeasurements of defined benefit liability / (asset)

-16.9

-0.82

Equity instruments designated through other comprehensive income

-2.03

-6.1

Income tax related to equity instruments designated through other comprehensive income

-5.02

0.7

Other comprehensive income (net of tax)

43.2

-2.95

Total comprehensive income for the year

4,086.04

6,803.93

Basic earnings per share

 

 

Basic earnings per share

101.17

170.34

Diluted earnings per share

101.17

170.34

Martin and Harris Laboratories Limited Consolidated Cash Flow Statement (Rs in Lakhs)

Particulars

31-03-2024

31-03-2023

Cash flow from operating activities

 

 

Net Profit before extraordinary items and tax

5,522.24

9,208.69

Adjustments

 

 

Interest received

-3,255.11

-2127.97

Grants written back

-2.32

-2.32

Rent received

-92.39

-75.23

Gain on sale of investments

-

-77.33

Interest paid

49.35

11.05

Depreciation and amortisation

463.14

392.85

Depreciation written back

-9.11

-

Profit on sale of Assets

-13.69

-

Operating profit before working capital changes

2662.12

7,239.73

Changes in working capital:

 

 

Decrease / (Increase) in inventories

-1,165.11

530.59

(Increase) in trade receivables

-60.3

-136.91

(Increase) in current financial loans

3,009.46

-3,009.46

Decrease / (Increase) in other current financial assets

-815.62

-37463.08

Decrease in other current assets

-759.25

102.82

Increase in non-current provisions

-44.97

3

Increase / (Decrease) in trade payables

710.72

457.74

Increase/(Decrease) in other current financial liabilities

-149.86

218.18

(Decrease) / Increase in other current liabilities

-69.6

67.93

Increase in current provisions

25.96

16.74

Cash generated from operations

3343.53

-31,972.73

Net income tax (paid)

-1386.23

2,429.09

Net cash flow generated from operating activities

1957.3

-34,401.82

Cash flow from investing activities

 

 

Purchase of property, plant and equipment, intangible assets, and capital work-in-progress

-1,171.13

-824.50

Sale proceeds of property, plant, and equipment

1,013.95

-

Sale proceeds of Investment Property

50

-

Bank deposits placed / matured during the year

-4,405.99

-

Purchase of non-current investments

-956.34

-32,601.59

Proceeds from sale of investments

-

63,677.33

Rent received

92.39

75.23

Interest received

3,255.11

2,217.97

Net cash flow (used in) investing activities

-2122.02

-32,544.44

Cash flow from financing activities

 

 

(Repayment) / Proceeds of short-term borrowings (net)

364.02

24.74

Interest paid

-49.35

11.05

Final dividend paid

-207.79

-207.79

Net cash flow (used in) financing activities

106.87

194.10

Net (decrease) in Cash and cash equivalents

-57.85

-2050.48

Cash and cash equivalents at the beginning of the year

82.47

2132.95

Cash and cash equivalents at the end of the year

24.62

82.47

Here is a summary of the Cash Flow Statement for the years 2024 and 2023:

Cash Flow from Operating Activities

Net Profit before Extraordinary Items and Tax:

In FY 2024, the company generated a profit of ₹5,522.24 lakhs, which is lower than the previous year 's ₹9,208.69 lakhs. This decline could be due to various factors like reduced revenue or increased costs.

Adjustments:

Interest received, grants written back, rent received, and gain on sale of investments are subtracted because they are non-operating income. Interest received reduced significantly in FY 2024 to ₹3,255.11 lakhs from ₹2,127.97 lakhs in FY 2023. Other adjustments include interest paid and depreciation expenses.

Operating Profit before Working Capital Changes:

This figure reflects the core operational efficiency of the company. In FY 2024, it stands at ₹2,662.12 lakhs, indicating a decline compared to the previous year 's ₹7,239.73 lakhs.

Changes in Working Capital:

This section shows the impact of changes in current assets and liabilities. Key changes include a decrease in inventories in FY 2024 (-₹1,165.11 lakhs) and trade receivables (-₹60.3 lakhs). The cash generated from operations improved significantly in FY 2024 to ₹3,343.53 lakhs, while in FY 2023, it was a negative figure of -₹31,972.73 lakhs.

Net Income Tax (Paid):

In FY 2024, a net tax payment of -₹1,386.23 lakhs was made, whereas FY 2023 saw a tax refund of ₹2,429.09 lakhs.

Net Cash Flow from Operating Activities:

The net cash flow generated from operations in FY 2024 was ₹1,957.30 lakhs, a significant turnaround from the previous year 's negative cash flow of -₹34,401.82 lakhs, indicating better operational efficiency or improved working capital management.

Cash Flow from Investing Activities

Purchase and Sale of Assets:

The company invested in property, plant, and equipment, resulting in a cash outflow of -₹1,171.13 lakhs in FY 2024, compared to -₹824.50 lakhs in FY 2023.

Sale proceeds from property and investment properties contributed positively to the cash flow, with ₹1,013.95 lakhs and ₹50 lakhs, respectively, in FY 2024.

Investments:

The company made significant investments in non-current assets, leading to a net cash outflow. In FY 2024, bank deposits and purchase of non-current investments led to an outflow of -₹4,405.99 lakhs and -₹956.34 lakhs, respectively. Proceeds from the sale of investments were substantial in FY 2023 (₹63,677.33 lakhs), but no such proceeds were noted in FY 2024.

Net Cash Flow (Used in) Investing Activities:

The net cash flow used in investing activities was -₹2,122.02 lakhs in FY 2024, slightly better than the previous year 's -₹32,544.44 lakhs, showing a reduced level of capital investment or more efficient use of assets.

Cash Flow from Financing Activities

Borrowings:

There was a net inflow from short-term borrowings of ₹364.02 lakhs in FY 2024, compared to ₹24.74 lakhs in FY 2023, indicating a reliance on external financing for operations or investments.

Interest and Dividends:

Interest paid was minimal in FY 2024 (-₹49.35 lakhs) and interest payments in FY 2023 also included dividends paid (-₹207.79 lakhs in both years). The impact of these outflows affected the overall cash flow from financing activities.

Net Cash Flow (Used in) Financing Activities:

The net cash inflow from financing activities was ₹106.87 lakhs in FY 2024, showing an improvement compared to ₹194.10 lakhs in FY 2023. This positive cash flow indicates an increased focus on managing debt and financing costs.

Net Decrease in Cash and Cash Equivalents

The overall cash position decreased by -₹57.85 lakhs in FY 2024 compared to a significant decrease of -₹2,050.48 lakhs in FY 2023. Despite the decrease, the company managed to maintain a better cash flow position in FY 2024.

Cash and Cash Equivalents:

Cash and cash equivalents stood at ₹24.62 lakhs at the end of FY 2024, compared to ₹82.47 lakhs at the end of FY 2023. This decline indicates that while the company improved its operational cash flow, other activities like investing and financing consumed a significant amount of cash.

Dividend History

Particulars

2024

2023

Dividend Per Share (in rs.)

5.2

5.2

Retained Earnings (Rs. In Lakhs)

62,237.12

58,351.82

Martin and Harris Laboratories Limited Recent Financial Performance

Dividend per Share: The specific dividend per share figure for 2024 and 2023 is Rs. 5.2 and Rs. 5.2 Per share. Dividend per share represents the portion of a company 's earnings that is distributed to shareholders in the form of dividends. A higher dividend per share may indicate that the company is sharing more of its profits with shareholders.

Retained Earnings: Retained earnings for 2024 amounted to Rs 62,237.12 Lakhs, while in 2023, they were Rs. 58,351.82 Lakhs. Retained earnings represent the portion of a company 's profits that is reinvested in the business rather than distributed as dividends. An increase in retained earnings suggests that the company has retained more of its profits for reinvestment or future growth.

To provide a more comprehensive analysis, it would be necessary to consider additional financial metrics such as revenue, net profit, assets, liabilities, and cash flows. Additionally, an analysis of trends over multiple years and a comparison to industry benchmarks and competitors would help in assessing the company 's financial health and performance

 

Martin & Harris Annual Reports

Martin And Harris Annual Report 2019-20

Download

Martin & Harris Annual Report 2023-2024

Download

Martin & Harris Annual Report 2021-2022

Download

Recent News

Wealth Wisdom - WWIPL
Support Megha Support Neha

News Alert